News & Views | Published:

Cell metabolism

Autophagy transcribed

Nature volume 516, pages 4041 (04 December 2014) | Download Citation

Two studies find that an intracellular quality-control mechanism called autophagy is regulated by nuclear receptor proteins that govern the expression of autophagy genes. See Letters p.108 & p.112

During periods of starvation, cells survive by changing their status, minimizing the energy spent on biosynthesis and instead activating catabolic pathways that release energy from intracellular stores. This adaptation requires autophagy1, a process by which intracellular substrates are transported to a subcellular compartment called the lysosome, then degraded and recycled. Although the mechanisms underlying the regulation of autophagy have long been considered to be post-transcriptional, recent studies2 have uncovered a role for transcriptional networks in the process. Two papers3,4 in this issue describe a previously unknown transcriptional mechanism that regulates autophagy in response to nutrient availability.

The emerging picture of how autophagy is regulated is of a biphasic mechanism of short- and long-term responses. In the cytoplasm, post-translational protein modifications and protein–protein interactions mediate the rapid induction of the pathway, but nuclear transcriptional mechanisms are necessary for a sustained response2. Such transcriptional regulation ensures that the proteins required for lysosome formation and autophagy are produced in appropriate quantities during long periods of nutrient shortage.

FXR is a nuclear receptor protein that is active during normal feeding conditions and regulates bile-acid, lipid and glucose metabolism5. Using mouse models and pharmacological approaches, Seok et al.3 (page 108) and Lee et al.4 (page 112) both demonstrated that FXR is a repressor of autophagy in the liver, the first direct evidence of a link between nuclear receptors and autophagy. However, the two studies report different underlying mechanisms for this repression. Seok and colleagues found that active FXR blocks autophagy by inhibiting the transcriptional activity of CREB, a protein that promotes the expression of several autophagy genes. FXR mediates such inhibition by disrupting the functional interaction between CREB and its coactivator protein CRTC2. By contrast, Lee and co-workers showed that FXR binds directly to the promoter-DNA regions that regulate the expression of several autophagy genes, leading to their repression.

Notably, Lee et al. showed that the binding of FXR to promoter DNA occurs at regions called DR1 sites, which can also be bound by the nuclear receptor protein PPAR-α. Like FXR, PPAR-α is involved in lipid metabolism, but unlike FXR, it is activated by fasting and promotes the production of energy from the degradation of liver fatty acid5. The authors found that PPAR-α induces the expression of autophagy genes, whereas FXR represses it. Thus, the two factors antagonistically regulate the autophagic response to nutrient availability by competing for the same binding sites on DNA.

The apparent discrepancy between the mechanisms proposed in the two papers probably reflects the complexity of the machinery involved in the regulation of autophagy in response to nutrient levels. FXR may repress transcription through many mechanisms to fine-tune autophagy. Moreover, only a fraction of the DNA sites bound by FXR are bound by CREB, supporting the possibility that, under normal feeding conditions, FXR can inhibit autophagy through CREB-independent mechanisms. It is also possible that the two mechanisms reported are differentially activated in response to different nutritional cues.

The number of autophagy genes whose expression seems to be controlled either directly or indirectly by FXR/CREB and PPAR-α is remarkable, and includes genes involved in several steps of autophagy. For example, Seok et al. showed that CREB induces autophagy through the direct transcriptional activation of the TFEB protein, a master regulator of lysosome biogenesis and of autophagy6. TFEB also promotes the expression and activity of PPAR-α, thereby activating lipid-degradation pathways in the liver7. Thus, these findings suggest that CREB and TFEB, as well as the nuclear receptor proteins FXR and PPAR-α, all belong to the same transcriptional network, which is regulated by nutrients and controls autophagy (Fig. 1). This transcriptional program operates in the nucleus, but has intimate connections with the cytoplasmic pathways that regulate the rapid induction of autophagy. The nutrient-sensing kinase enzyme mTORC1, a regulator of starvation-induced autophagy, mediates these interactions by holding TFEB in the cytoplasm in fed conditions, but permitting nuclear entry during fasting8, and regulating nuclear entry of NCoR1, a transcriptional repressor of PPAR-α, in the opposite manner9.

Figure 1: Regulation of starvation-induced autophagy.
Figure 1

Seok et al.3 and Lee et al.4 report that the nuclear receptor protein FXR regulates autophagy. a, In normal feeding conditions, FXR inhibits the formation of the CRTC2–CREB protein complex by binding CREB, and competes with another nuclear receptor protein, PPAR-α, for binding sites on gene-promoter regions. Fed conditions also mean that the autophagy-promoting transcription factor TFEB is unable to enter the nucleus because it is bound by the protein mTORC1, which is located on structures called lysosomes. Finally, the transcriptional repressor protein NCoR1 (which is activated by mTORC1) binds DNA. Together, these actions repress the transcription of autophagy genes. b, During fasting, FXR is inactive, leading to PPAR-α–promoter binding. This activates the transcription of lysosomal and autophagy genes. In the absence of FXR, the CRTC2–CREB complex forms, which activates transcription of the gene encoding TFEB. This protein is not held by mTORC1 in fasting conditions and can therefore promote transcription of autophagy genes, including that encoding PPAR-α. The co-repressor NCoR1, however, is no longer activated by mTORC1 and is held in the cytoplasm.

A role for autophagy in lipid degradation has already been described — in a process called lipophagy, lipid droplets are internalized in autophagic vesicles and then delivered to lysosomes for degradation10. The various lipid-degradation mechanisms that operate in different cellular compartments, such as the nucleus, lysosomes, autophagic vesicles and mitochondria, require an integrated regulatory network that is just beginning to emerge. The current studies clearly show that FXR and PPAR-α regulate lipophagy at the transcriptional level.

A link between autophagy and nuclear receptors expands our knowledge of the autophagy repertoire, because nuclear receptors are involved in a multitude of pathways. More studies are needed to fully understand how different physiological and pathological conditions regulate the process. Furthermore, it remains to be determined whether or not the transcriptional mechanisms that mediate the response to starvation are also used to respond to other energy-demanding conditions, such as physical exercise and low temperature, or to diseases such as cancer. Finally, pharmacological modulation of these pathways might point to possible therapeutic strategies for combating a broad range of diseases.

References

  1. 1.

    & Science 330, 1344–1348 (2010).

  2. 2.

    , & Nature Rev. Mol. Cell Biol. 15, 65–74 (2014).

  3. 3.

    et al. Nature 516, 108–111 (2014).

  4. 4.

    et al. Nature 516, 112–115 (2014).

  5. 5.

    & Cell 157, 255–266 (2014).

  6. 6.

    et al. Science 332, 1429–1433 (2011).

  7. 7.

    et al. Nature Cell Biol. 15, 647–658 (2013).

  8. 8.

    et al. EMBO J. 31, 1095–1108 (2012).

  9. 9.

    , , , & Nature 468, 1100–1104 (2010).

  10. 10.

    et al. Nature 458, 1131–1135 (2009).

Download references

Author information

Affiliations

  1. Carmine Settembre and Andrea Ballabio are at the Telethon Institute of Genetics and Medicine, Naples 80078, Italy; in the Department of Translational Medicine, Federico II University, Naples; and in the Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

    • Carmine Settembre
    •  & Andrea Ballabio

Authors

  1. Search for Carmine Settembre in:

  2. Search for Andrea Ballabio in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nature13939

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing